Carbohydrate antigen 19-9 elevation in anatomically resectable, early stage pancreatic cancer is independently associated with decreased overall survival and an indication for neoadjuvant therapy: A national cancer database study

John R. Bergquist, Carlos A. Puig, Christopher R. Shubert, Ryan T. Groeschl, Elizabeth B. Habermann, Michael L. Kendrick, David M. Nagorney, Rory L. Smoot, Michael B. Farnell, Mark J. Truty

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Carbohydrate antigen 19-9 elevation in anatomically resectable, early stage pancreatic cancer is independently associated with decreased overall survival and an indication for neoadjuvant therapy: A national cancer database study'. Together they form a unique fingerprint.

Medicine & Life Sciences